NEW YORK, Oct. 21, 2022 (GLOBE NEWSWIRE) — Scott+Scott Attorneys LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Dentsply Sirona Inc. (“Dentsply”) (NASDAQ: XRAY) have failed in their fiduciary duties to Dentsply and its shareholders. If you are a Dentsply shareholder, you can contact Attorney Joe Pettigrew toll-free at 844-818-6982 or for more information [email protected].

Scott+Scott is investigating whether members of Dentsply’s board of directors (the “Board”) are making false and/or misleading statements about Dentsply’s business, operations, prospects and financial health. In particular, Scott+Scott is investigating whether the Board of Directors failed to disclose material information, including whether: (i) Dentsply incorrectly recognized revenue associated with certain dealer incentives or rebate programs to allow its former Chief Executive Officer (“CEO”) and Chief enable Financial Officer (“CFO”) to achieve certain incentive-based compensation targets; and (ii) consequently, whether statements about Dentsply’s business, operations and prospects were not based on reasonable grounds.

On April 19, 2022, Dentsply announced the sudden termination of its CEO. As a result of this news, the price of Dentsply shares fell by 13%. On May 10, 2022, Dentsply announced that the Audit Committee of the Board of Directors has opened an internal investigation regarding Dentsply’s “use of inducements to sell products to distributors” and “whether such inducements have been properly addressed.” As a result, Dentsply failed to file its quarterly report with the SEC. As a result of this news, Dentsply shares fell by 7%.

What you can do

If you are a Dentsply shareholder, you may have legal claims against Dentsply directors and officers. If you would like to discuss this investigation or…